Athena Countouriotis Insider Trading $ADVM Adverum Biotechnologies, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Athena Countouriotis.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Athena Countouriotis. Athena Countouriotis is SVP and Chief Medical Officer in HALOZYME THERAPEUTICS INC ($GYHT) and Chief Medical Officer in AMBIT BIOSCIENCES CORP ($AMBI) and Director in Trovagene, Inc. ($XNOM.OB) and Director in IOVANCE BIOTHERAPEUTICS, INC. ($IOVA) and SVP, Chief Medical Officer in Adverum Biotechnologies, Inc. ($ADVM) and President & CEO in Turning Point Therapeutics, Inc. ($TPTX) and Director in Passage BIO, Inc. ($PASG).

Athena Countouriotis in Adverum Biotechnologies, Inc.

Trading Symbol: ADVM
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Athena Countouriotis: SVP, Chief Medical Officer
Holdings: 150,000 shares
Latest Transaction: Feb 20 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Athena Countouriotis in Adverum Biotechnologies, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADVM, AMBI, XNOM.OB, GYHT, IOVA, PASG, TPTX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 20 2018	ADVM	Adverum Biotechnol ...	Countouriotis Athena	SVP, Chief Medical ...	Option Exercise	A	6.40	160,000	1,024,000	160,000
Jun 21 2017	ADVM	Adverum Biotechnol ...	Countouriotis Athena	SVP, Chief Medical ...	Option Exercise	A	2.90	213,000	617,700	213,000
Jun 21 2017	ADVM	Adverum Biotechnol ...	Countouriotis Athena	SVP, Chief Medical ...	Grant	A	0.00	150,000	0	150,000	0 to 150 K

Page: 1